Vimarsana
Biggest News Aggregation in the World

Lab Diagnostics Automation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lab Diagnostics Automation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lab Diagnostics Automation Today - Breaking & Trending Today

Using cationic nanonmaterials to target visceral adiposity - Vimarsana News

Using cationic nanonmaterials to target visceral adiposity

Researchers have long been working on how to treat obesity, a serious condition that can lead to hypertension, diabetes, chronic inflammation, and cardiovascular diseases.

Study identifies optimal blood tests for Alzheimer's detection and disease monitoring - Vimarsana News

Study identifies optimal blood tests for Alzheimer's detection and disease monitoring

A new study have identified which blood tests are best at detecting Alzheimer's disease during the earliest stages, and another blood test that is optimal for detecting relevant treatment effects.

New evidence on the links between immune activation and neuroinflammation and Parkinson's disease - Vimarsana News

New evidence on the links between immune activation and neuroinflammation and Parkinson's disease

In this special supplement to the Journal of Parkinson's Disease, "The Immune System in Parkinson's Disease," experts highlight the latest research breakthroughs on the links between immune activation and neuroinflammation and Parkinson's disease (PD) and discuss the challenges and novel therapeutic strategies targeting the immune system with the hope of reducing or reversing neurodegeneration.

First-in-humans test provides promising results for a broadly neutralizing antibody HIV vaccine - Vimarsana News

First-in-humans test provides promising results for a broadly neutralizing antibody HIV vaccine

A Phase 1 clinical trial provides promising results for a broadly neutralizing antibody (bnAb) HIV vaccine, according to a new study.

Gargling with povidone-iodine may reduce salivary viral load in COVID-19 patients - Vimarsana News

Gargling with povidone-iodine may reduce salivary viral load in COVID-19 patients

A prospective, randomized, open-level clinical trial demonstrates that gargling with povidone-iodine accelerates viral clearance and reduces saliva infectivity in patients with asymptomatic or mild coronavirus disease 2019 (COVID-19). The trial findings have been published in the journal Scientific Reports.